Abdominal Stent Graft System Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Abdominal Stent Graft System Market is Segmented by Type (Metal stent and Polymer stent), End-User (Hospitals, Ambulatory Surgical Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Abdominal Stent Graft System Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Abdominal Stent Graft System Market Size

Abdominal Stent Graft System Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 4.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Abdominal Stent Graft System Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Abdominal Stent Graft System Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Abdominal Stent Graft System Market Analysis

The Abdominal Stent Graft System Market is expected to register a CAGR of 4.1% during the forecast period.

  • COVID-19 significantly impacted the abdominal stent graft system market during the initial wave since COVID-19 patients with aortic aneurysms faced an increased risk of disease complications. For instance, as per the article published in January 2022 in PubMed, COVID-19 infection may cause abdominal aortic aneurysm (AAA) degeneration in many ways. Several processes associated with COVID-19 infection, including higher levels of inflammatory cytokines, have the potential to activate metalloproteinases capable of digesting collagen and elastin, leading to AAA wall degradation.
  • Hence, as COVID-19 patients with AAA were at risk of complications, the demand for the abdominal stent graft system increased during the pandemic. In the post-pandemic era, the market is estimated to witness growth in the future due to the increase in cases of AAA and the rise in the risk of occlusive atherosclerotic disease among the population worldwide.
  • The major factors attributing to the growth of the abdominal stent graft system market are the increasing prevalence of abdominal aortic aneurysms, the rise in the population prone to the risk of occlusive atherosclerosis disease, and the increasing adoption of minimally invasive surgeries. Also rise in the geriatric population is one of the major reasons for the adoption of the abdominal stent graft system market. For instance, as per the Abdominal aortic aneurysm screening: standards report 2021 to 2022 published by the Government of the UK, approximately 274,800 men were offered screening, with 79.0% receiving a conclusive screen during the period of 1st April 2021 to 31 March 2022, in which 1,794 aneurysms (aorta measuring more than or equal to 3.0cm) were found. Thus increase in aneurysm cases is expected to drive market growth over the forecast period.
  • Furthermore, as per the World Population Prospectus 2022 update, the percentage of the population of people aged 65 years or over in the world was estimated to be 9.7 in 2022, and the percentage is expected to rise to 16.4 by 2050. Since the geriatric population is more prone to affecting occlusive atherosclerotic disease, which leads to the adoption of abdominal stent grafts, the rise in the geriatric population bolsters the market growth over the forecast period.
  • Moreover, the technological advancements in stents, increasing adoption of MIS procedures, and presence of competitors are expected to increase the availability of the abdominal stent graft system, leading to market growth. For instance, in May 2021, Endologix launched an implant of its Alto abdominal stent graft in Canada following approval from Health Canada. Alto was also approved for commercial sale in Argentina.
  • The alto abdominal stent graft system is the latest generation in polymer-based therapies for abdominal aortic aneurysm (AAA) patients. The device utilizes a low-profile delivery system and, unlike standard endovascular aneurysm repair (EVAR) devices, features an exclusive conformable sealing ring that molds in situ to the patient's specific aortic neck anatomy.
  • Thus, considering the high prevalence of abdominal aortic aneurysms, the rise in the geriatric population, the technological advancements in stents, and the increasing adoption of MIS procedures, the studied market is expected to witness significant growth over the forecast period. However, the high cost of surgery and lack of long-term benefits are expected to restrain the market growth over the forecast period.

Abdominal Stent Graft System Industry Overview

The abdominal stent graft system market is highly competitive and consists of many global players. The key players are focused on strategic initiatives such as mergers, acquisitions, partnerships, and product launches to increase global product availability. Some of the key players in the market are Endologix, Inc., Sofmedica, Terumo Corporation, Medtronic, Jotec GmbH, Cook Medical, Microport Scientific Corporation, Cardinal Health, Inc., and many others.

Abdominal Stent Graft System Market Leaders

  1. Endologix, Inc

  2. Sofmedica

  3. Terumo Corporation

  4. Artivion, Inc

  5. Cook Group

  6. *Disclaimer: Major Players sorted in no particular order
Abdominal Stent Graft System Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Abdominal Stent Graft System Market News

  • October 2022: Endologix LLC revealed that its ELEVATE (Expanding Patient Applicability with Polymer Sealing Ovation ALTO Stent Graft) IDE study was published online in the Journal of Vascular Surgery. The study reported the clinical outcomes of the ALTO abdominal stent graft system and highlighted the device's safety and effectiveness at one-year post-procedure.
  • August 2022: Endologix LLC, a privately held medical device company, received CE Mark Certification under the new EU Medical Devices Regulation for its AFX2 Endovascular AAA System. The AFX endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft material technology to treat a variety of anatomies.

Abdominal Stent Graft System Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Abdominal Aortic Aneurysm
    • 4.2.2 Increase in the Geriatric Population and Risk of Occlusive Atherosclerotic Disease
    • 4.2.3 Technological Advancements in Stents & Increasing Adoption of MIS Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgery and Treatment
    • 4.3.2 Lack of Long Term Outcome Benefits
  • 4.4 Porters Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Metal Stent
    • 5.1.2 Polymer Stent
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Endologix, Inc.
    • 6.1.2 Sofmedica
    • 6.1.3 Terumo Corporation
    • 6.1.4 Medtronic
    • 6.1.5 Lombard Medical
    • 6.1.6 Cook medical
    • 6.1.7 Microport Scientific Corporation
    • 6.1.8 Cardinal Health, Inc.
    • 6.1.9 JOTEC GmbH
    • 6.1.10 Braile Biomédica
    • 6.1.11 Bentley
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Abdominal Stent Graft System Industry Segmentation

As per the scope of the report, the abdominal stent graft system is used to repair a weakened and bulging part of the aorta, which is the largest part of the abdomen, below the renal arteries. The system comprises an implant, extension implants, and a catheter. The abdominal stent graft system is majorly used in the treatment of abdominal aortic aneurysms (AAA). 

The abdominal stent graft system market is segmented by type (metal stent and polymer stent), end-user (hospitals, ambulatory surgical centers, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Type Metal Stent
Polymer Stent
By End-User Hospitals
Ambulatory Surgical Centers
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Abdominal Stent Graft System Market Research FAQs

What is the current Abdominal Stent Graft System Market size?

The Abdominal Stent Graft System Market is projected to register a CAGR of 4.1% during the forecast period (2025-2030)

Who are the key players in Abdominal Stent Graft System Market?

Endologix, Inc, Sofmedica, Terumo Corporation, Artivion, Inc and Cook Group are the major companies operating in the Abdominal Stent Graft System Market.

Which is the fastest growing region in Abdominal Stent Graft System Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Abdominal Stent Graft System Market?

In 2025, the North America accounts for the largest market share in Abdominal Stent Graft System Market.

What years does this Abdominal Stent Graft System Market cover?

The report covers the Abdominal Stent Graft System Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Abdominal Stent Graft System Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Abdominal Stent Graft System Industry Report

Statistics for the 2025 Abdominal Stent Graft System market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Abdominal Stent Graft System analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.